Received Mar 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y017062 | — |
Symptoms were not reported.; Customer called to report TE. Vaccines were administered to patients.; This spontaneous report was received from a medical assistant and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 09-Feb-2026, the patient was vaccinated with improper stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), formulation: injection, lot #Y017062, expiration date: 11-Oct-2026 (exact dose, route of administration and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (lot # and expiration date were not reported). Administered dose of vaccine was exposed to the temperature excursion of -14 degrees Celsius (C) up to -10 C (-13.6 C) for 2 hours and 5 minutes (product storage error). No additional adverse event reported (no adverse event).
MERCK STERILE DILUENT